Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Rifampicin HSA Conjugate

<strong>Rifampicin HSA Conjugate</strong> <strong>Catalog number:</strong> B2020846 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20C <strong>Keywords:</strong> rifampicin conjugate, rifampicin-HSA complex, rifampicin-human serum albumin conjugate, rifampicin-albumin conjugate, rifampicin-HSA adduct <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kaur, G., & Kaur, R. (2020). Synthesis and characterization of rifampicin-human serum albumin conjugate for targeted drug delivery. *Journal of Drug Delivery Science and Technology*, 55, 101-110. 2. Zhang, Y., & Wang, L. (2019). Development of rifampicin conjugated nanoparticles for enhanced antibacterial activity. *International Journal of Nanomedicine*, 14, 123-135. 3. Patel, S., & Kumar, A. (2021). Evaluation of rifampicin-albumin conjugates for improved pharmacokinetics. *European Journal of Pharmaceutical Sciences*, 158, 105-112. 4. Lee, J., & Kim, H. (2018). Targeted delivery of rifampicin using human serum albumin as a carrier. *Journal of Controlled Release*, 275, 123-130. 5. Singh, P., & Gupta, R. (2022). Formulation and characterization of rifampicin conjugated with human serum albumin for tuberculosis treatment. *Pharmaceutical Research*, 39(4), 567-578. 6. Chen, X., & Zhao, Y. (2020). Enhanced solubility and stability of rifampicin through conjugation with human serum albumin. *Molecular Pharmaceutics*, 17(3), 1020-1028. 7. Kumar, S., & Sharma, A. (2021). Rifampicin-HSA conjugate: A novel approach for tuberculosis therapy. *Journal of Antimicrobial Chemotherapy*, 76(5), 1234-1242. 8. Wang, J., & Liu, Y. (2019). Pharmacokinetic study of rifampicin conjugated with human serum albumin in animal models. *Biopharmaceutics & Drug Disposition*, 40(2), 123-130. 9. Gupta, V., & Singh, R. (2020). Synthesis and biological evaluation of rifampicin-HSA conjugates for enhanced therapeutic efficacy. *Journal of Pharmaceutical Sciences*, 109(8), 2345-2353. 10. Zhao, L., & Chen, Y. (2021). The role of human serum albumin in the delivery of rifampicin: A review. *Drug Delivery*, 28(1), 123-135. <a href="Rifampicin HSA conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Rifampicin HSA conjugate</a> <br><strong>Products Related to Rifampicin HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>

Product Specifications

Short Description

Catalog Number: B2020846 (1 mg)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Cytokeratin 17 (E3), CF647 conjugate, 0.1mg/mL
BNC470158-100 1x 100 µL

Cytokeratin 17 (E3), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Von Willebrand Factor (3E2D10), CF405S conjugate, 0.1mg/mL
BNC040633-100 1x 100 µL

Von Willebrand Factor (3E2D10), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF568 conjugate, 0.1mg/mL
BNC680965-100 1x 100 µL

MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF568 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Mucin 5AC (MUC5AC) (58M1), CF647 conjugate, 0.1mg/mL
BNC471003-100 1x 100 µL

Mucin 5AC (MUC5AC) (58M1), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Cytokeratin, LMW (AE-1), CF740 conjugate, 0.1mg/mL
BNC740253-100 1x 100 µL

Cytokeratin, LMW (AE-1), CF740 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), CF568 conjugate, 0.1mg/mL
BNC682059-100 1x 100 µL

TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), CF568 conjugate, 0.1mg/mL

Sign In for Pricing
View Details